ArticleCurrent oncology (Toronto, Ont.)2024

Real-World Characterization of Toxicities and Medication Management in Recipients of CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma in Nova Scotia, Canada.

Jenna Shaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.